| Physical and chemical screening of honey samples available in the Saudi market: An important aspect in the authentication process and quality assessment HI Aljohar, HM Maher, J Albaqami, M Al-Mehaizie, R Orfali, R Orfali, ... Saudi Pharmaceutical Journal 26 (7), 932-942, 2018 | 106 | 2018 |
| Mass spectrometry‐based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin ZM Al‐Majdoub, B Achour, N Couto, M Howard, Y Elmorsi, D Scotcher, ... FEBS letters 594 (23), 4134-4150, 2020 | 25 | 2020 |
| Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: applications in translational pharmacology and recommendations for best practice E El-Khateeb, AM Vasilogianni, S Alrubia, ZM Al-Majdoub, N Couto, ... Pharmacology & Therapeutics 203, 107397, 2019 | 22 | 2019 |
| Altered bioavailability and pharmacokinetics in Crohn’s disease: Capturing systems parameters for PBPK to assist with predicting the fate of orally administered drugs S Alrubia, J Mao, Y Chen, J Barber, A Rostami-Hodjegan Clinical Pharmacokinetics 61 (10), 1365-1392, 2022 | 11 | 2022 |
| Proteomic quantification of perturbation to pharmacokinetic target proteins in liver disease AM Vasilogianni, E El-Khateeb, ZM Al-Majdoub, S Alrubia, ... Journal of Proteomics 263, 104601, 2022 | 9 | 2022 |
| Quantitative Assessment of the Impact of Crohn's Disease on Protein Abundance of Human Intestinal Drug-Metabolising Enzymes and Transporters S Alrubia, ZM Al-Majdoub, B Achour, A Rostami-Hodjegan, J Barber Journal of Pharmaceutical Sciences 111 (10), 2917-2929, 2022 | 8 | 2022 |
| A family of QconCATs (Quantification conCATemers) for the quantification of human pharmacological target proteins AM Vasilogianni, E El-Khateeb, B Achour, S Alrubia, A Rostami-Hodjegan, ... Journal of Proteomics 261, 104572, 2022 | 4 | 2022 |
| Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind … E El-Khateeb, EI El-Berri, EM Mosalam, MZ Nooh, S Abdelsattar, ... Frontiers in Pharmacology 14, 1153653, 2023 | 3 | 2023 |
| Label-free but still constrained: assessment of global proteomic strategies for the quantification of hepatic enzymes and transporters J Barber, ZM Al-Majdoub, N Couto, AM Vasilogianni, A Tillmann, ... Drug Metabolism and Disposition 50 (6), 762-769, 2022 | 3 | 2022 |
| Complementarity of two proteomic data analysis tools in the identification of drug-metabolising enzymes and transporters in human liver AM Vasilogianni, S Alrubia, E El-Khateeb, ZM Al-Majdoub, N Couto, ... Molecular Omics, 2024 | | 2024 |
| The Impact of Crohn's Disease on the Expression of Intestine Drug Metabolising Enzymes and Transporters-Implications in Oral Drugs Disposition S Alrubia The University of Manchester, Manchester, UK, 2022 | | 2022 |
Amin Rostami-HodjeganProfessor of Systems Pharmacology, University of Manchester, UKVerified email at manchester.ac.uk
